0558 GMT May 27, 2019
Speaking to IRNA after his negotiations with his Iraqi counterpart Alaeddin Alvan, Namaki said Iran is not seeking special interests from the Iraqi market. Iran aims to help solve the Iraqi people's problems in supply and demand.
He added that Iran’s plan is to start joint investment through the private sector and semi-state-run sectors.
He said that the agenda of his visit to Baghdad is to make preparatory works for Iran's participation in the Iraqi pharmaceutical market.
Based on negotiations held with his Iraqi counterpart, Iran is after setting a timetable for the registration of pharmaceutical items, he noted.
Namaki went on to say that Iran has 125 products in Iraq’s pharmaceutical export list.
Stressing that 97 percent of Iran’s pharmaceutical demands are produced domestically, he said Iran is ready to share its experiences in the medical field and in developing the health and treatment infrastructure in Iraq.
Meanwhile, Alvan referred to Iran's great success in the health field, saying cooperation with Iran will pave the way for Iraq to take advantage of Iran’s experiences to modify its health system.
Leading a delegation, Iran's health minister arrived in Baghdad at the invitation of his Iraqi counterpart.
A number of local officials and Majlis representatives are also accompanying the health minister.
Referring to the memoranda of understanding (MoUs) signed earlier between the two countries’ health ministries, he pointed out that the issue has nothing to with the US unilateral sanctions, as the two countries are trying to further improve bilateral relations.